Found: 32
Select item for more details and to access through your institution.
Correction to: Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Role of ferroptosis in hepatocellular carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 12, p. 2329, doi. 10.1007/s00432-018-2740-3
- By:
- Publication type:
- Article
Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 10, p. 1597, doi. 10.1007/s00432-010-0817-8
- By:
- Publication type:
- Article
BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.08401
- By:
- Publication type:
- Article
Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0969-y
- By:
- Publication type:
- Article
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-133
- By:
- Publication type:
- Article
LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-114
- By:
- Publication type:
- Article
A preliminary study of ALPPS procedure in a rat model.
- Published in:
- Scientific Reports, 2015, v. 5, n. 1, p. 17567, doi. 10.1038/srep17567
- By:
- Publication type:
- Article
Diphenyl Difluoroketone: A Potent Chemotherapy Candidate for Human Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023908
- By:
- Publication type:
- Article
Long non-coding RNA <italic>NEAT1</italic>-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation.
- Published in:
- Molecular Cancer, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12943-018-0838-5
- By:
- Publication type:
- Article
STING: a master regulator in the cancer-immunity cycle.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-019-1087-y
- By:
- Publication type:
- Article
The aberrant expression of rhythm genes affects the genome instability and regulates the cancer immunity in pan‐cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1818, doi. 10.1002/cam4.2834
- By:
- Publication type:
- Article
Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.764189
- By:
- Publication type:
- Article
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.654076
- By:
- Publication type:
- Article
PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 111, n. 1, p. 218, doi. 10.1002/jcb.22691
- By:
- Publication type:
- Article
Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis.
- Published in:
- Nature Communications, 2013, v. 4, n. 12, p. 2996, doi. 10.1038/ncomms3996
- By:
- Publication type:
- Article
Role of microRNA in anticancer drug resistance.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 1, p. 2, doi. 10.1002/ijc.24782
- By:
- Publication type:
- Article
miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 7, p. N.PAG, doi. 10.1038/s41419-019-1715-x
- By:
- Publication type:
- Article
STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 2, p. 1, doi. 10.1038/s41419-018-0262-1
- By:
- Publication type:
- Article
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00200-4
- By:
- Publication type:
- Article
Immunoscore system combining CD8 and PD-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer.
- Published in:
- International Journal of Biological Markers, 2020, v. 35, n. 1, p. 65, doi. 10.1177/1724600819888771
- By:
- Publication type:
- Article
Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study.
- Published in:
- BMC Medical Imaging, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12880-021-00572-w
- By:
- Publication type:
- Article
Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00564-w
- By:
- Publication type:
- Article
FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-783
- By:
- Publication type:
- Article
lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2.
- Published in:
- Oncogenesis, 2020, v. 9, n. 5, p. 1, doi. 10.1038/s41389-020-0242-z
- By:
- Publication type:
- Article
Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.01118
- By:
- Publication type:
- Article
MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
- Published in:
- Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 2, p. 371, doi. 10.1111/j.1440-1746.2010.06440.x
- By:
- Publication type:
- Article
The status and progress of first-line treatment against Helicobacter pylori infection: a review.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284821989177
- By:
- Publication type:
- Article
The status and progress of first-line treatment against Helicobacter pylori infection: a review.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/1756284821989177
- By:
- Publication type:
- Article
Selecting molecular therapeutic drug targets based on the expression profiles of intrahepatic cholangiocarcinomas and miRNA-mRNA regulatory networks.
- Published in:
- Oncology Reports, 2016, v. 35, n. 1, p. 382, doi. 10.3892/or.2015.4330
- By:
- Publication type:
- Article
Pathophysiological mechanisms of ALPPS: experimental model.
- Published in:
- British Journal of Surgery, 2022, v. 109, n. 6, p. 510, doi. 10.1093/bjs/znac007
- By:
- Publication type:
- Article
FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
- Published in:
- 2014
- By:
- Publication type:
- journal article